Novo Nordisk CEO: ‘80% of Wegovy pill customers’ have never taken a GLP-1 before

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email

At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Novo Nordisk CEO Mike Doustdar to discuss the launch of the Wegovy pill and how it became the best prescription drug launch in history.

09:12

Tue, Jun 9 20262:26 PM EDT